[Federal Register: January 15, 2009 (Volume 74, Number 10)]
[Notices]
[Page 2619]
From the Federal Register Online via GPO Access [wais.access.gpo.gov]
[DOCID:fr15ja09-130]

-----------------------------------------------------------------------

DEPARTMENT OF JUSTICE

Drug Enforcement Administration


Importer of Controlled Substances; Notice of Registration

    By Notice dated October 6, 2008, and published in the Federal
Register on October 14, 2008, (73 FR 60719), Hospira Inc., 1776 North
Centennial Drive, McPherson, Kansas 67460-1247, made application by
renewal to the Drug Enforcement Administration (DEA) to be registered
as an importer of Remifentanil (9739), a basic class of controlled
substance listed in schedule II.
    The company plans to import Remifentanil for use in dosage form
manufacturing.
    No comments or objections have been received. DEA has considered
the factors in 21 U.S.C. 823(a) and 952(a) and determined that the
registration of Hospira, Inc. to import the basic class of controlled
substance is consistent with the public interest, and with United
States obligations under international treaties, conventions, or
protocols in effect on May 1, 1971, at this time. DEA has investigated
Hospira, Inc. to ensure that the company's registration is consistent
with the public interest. The investigation has included inspection and
testing of the company's physical security systems, verification of the
company's compliance with state and local laws, and a review of the
company's background and history. Therefore, pursuant to 21 U.S.C.
952(a) and 958(a), and in accordance with 21 CFR 1301.34, the above
named company is granted registration as an importer of the basic class
of controlled substance listed.

    Dated: January 9, 2009.
Joseph T. Rannazzisi,
Deputy Assistant Administrator, Office of Diversion Control, Drug
Enforcement Administration.
[FR Doc. E9-732 Filed 1-14-09; 8:45 am]

BILLING CODE 4410-09-P